Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 59

1.

Influenza virus exploits tunneling nanotubes for cell-to-cell spread.

Kumar A, Kim JH, Ranjan P, Metcalfe MG, Cao W, Mishina M, Gangappa S, Guo Z, Boyden ES, Zaki S, York I, García-Sastre A, Shaw M, Sambhara S.

Sci Rep. 2017 Jan 6;7:40360. doi: 10.1038/srep40360.

2.

Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease.

Kim JH, Reber AJ, Kumar A, Ramos P, Sica G, Music N, Guo Z, Mishina M, Stevens J, York IA, Jacob J, Sambhara S.

Sci Rep. 2016 Nov 16;6:37341. doi: 10.1038/srep37341.

3.

Glycosylation changes in the globular head of H3N2 influenza hemagglutinin modulate receptor binding without affecting virus virulence.

Alymova IV, York IA, Air GM, Cipollo JF, Gulati S, Baranovich T, Kumar A, Zeng H, Gansebom S, McCullers JA.

Sci Rep. 2016 Oct 31;6:36216. doi: 10.1038/srep36216.

4.

An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody with prophylactic and therapeutic activity in vivo.

Wilson JR, Guo Z, Reber A, Kamal RP, Music N, Gansebom S, Bai Y, Levine M, Carney P, Tzeng WP, Stevens J, York IA.

Antiviral Res. 2016 Nov;135:48-55. doi: 10.1016/j.antiviral.2016.10.001.

PMID:
27713074
5.

Antibody-Dependent Cell-Mediated Cytotoxicity to Hemagglutinin of Influenza A Viruses After Influenza Vaccination in Humans.

Zhong W, Liu F, Wilson JR, Holiday C, Li ZN, Bai Y, Tzeng WP, Stevens J, York IA, Levine MZ.

Open Forum Infect Dis. 2016 May 18;3(2):ofw102. doi: 10.1093/ofid/ofw102.

6.

Peripheral Leukocyte Migration in Ferrets in Response to Infection with Seasonal Influenza Virus.

Music N, Reber AJ, Kim JH, York IA.

PLoS One. 2016 Jun 17;11(6):e0157903. doi: 10.1371/journal.pone.0157903.

7.

RIG-I ligand enhances the immunogenicity of recombinant H7HA protein.

Cao W, Liepkalns JS, Kamal RP, Reber AJ, Kim JH, Hofstetter AR, Amoah S, Stevens J, Ranjan P, Gangappa S, York IA, Sambhara S.

Cell Immunol. 2016 Jun-Jul;304-305:55-8. doi: 10.1016/j.cellimm.2016.04.004.

PMID:
27106062
8.

A highly immunogenic vaccine against A/H7N9 influenza virus.

Cao W, Liepkalns JS, Hassan AO, Kamal RP, Hofstetter AR, Amoah S, Kim JH, Reber AJ, Stevens J, Katz JM, Gangappa S, York IA, Mittal SK, Sambhara S.

Vaccine. 2016 Feb 3;34(6):744-9. doi: 10.1016/j.vaccine.2015.12.062.

9.

Supplementation of H1N1pdm09 split vaccine with heterologous tandem repeat M2e5x virus-like particles confers improved cross-protection in ferrets.

Music N, Reber AJ, Kim MC, York IA, Kang SM.

Vaccine. 2016 Jan 20;34(4):466-73. doi: 10.1016/j.vaccine.2015.12.023.

10.

Diverse antigenic site targeting of influenza hemagglutinin in the murine antibody recall response to A(H1N1)pdm09 virus.

Wilson JR, Guo Z, Tzeng WP, Garten RJ, Xiyan X, Blanchard EG, Blanchfield K, Stevens J, Katz JM, York IA.

Virology. 2015 Nov;485:252-62. doi: 10.1016/j.virol.2015.08.004.

11.

Emergence of Highly Pathogenic Avian Influenza A(H5N1) Virus PB1-F2 Variants and Their Virulence in BALB/c Mice.

Kamal RP, Kumar A, Davis CT, Tzeng WP, Nguyen T, Donis RO, Katz JM, York IA.

J Virol. 2015 Jun;89(11):5835-46. doi: 10.1128/JVI.03137-14.

12.

An MHC class I immune evasion gene of Marek׳s disease virus.

Hearn C, Preeyanon L, Hunt HD, York IA.

Virology. 2015 Jan 15;475:88-95. doi: 10.1016/j.virol.2014.11.008.

13.

Non-avian animal reservoirs present a source of influenza A PB1-F2 proteins with novel virulence-enhancing markers.

Alymova IV, York IA, McCullers JA.

PLoS One. 2014 Nov 4;9(11):e111603. doi: 10.1371/journal.pone.0111603.

14.

Recombinant influenza H7 hemagglutinins induce lower neutralizing antibody titers in mice than do seasonal hemagglutinins.

Blanchfield K, Kamal RP, Tzeng WP, Music N, Wilson JR, Stevens J, Lipatov AS, Katz JM, York IA.

Influenza Other Respir Viruses. 2014 Nov;8(6):628-35. doi: 10.1111/irv.12285.

15.

Molecular determinants of influenza virus pathogenesis in mice.

Kamal RP, Katz JM, York IA.

Curr Top Microbiol Immunol. 2014;385:243-74. doi: 10.1007/82_2014_388. Review.

16.

Influenza vaccination accelerates recovery of ferrets from lymphopenia.

Music N, Reber AJ, Lipatov AS, Kamal RP, Blanchfield K, Wilson JR, Donis RO, Katz JM, York IA.

PLoS One. 2014 Jun 26;9(6):e100926. doi: 10.1371/journal.pone.0100926.

17.

Diversity of the murine antibody response targeting influenza A(H1N1pdm09) hemagglutinin.

Wilson JR, Tzeng WP, Spesock A, Music N, Guo Z, Barrington R, Stevens J, Donis RO, Katz JM, York IA.

Virology. 2014 Jun;458-459:114-24. doi: 10.1016/j.virol.2014.04.011.

18.

LABEL: fast and accurate lineage assignment with assessment of H5N1 and H9N2 influenza A hemagglutinins.

Shepard SS, Davis CT, Bahl J, Rivailler P, York IA, Donis RO.

PLoS One. 2014 Jan 23;9(1):e86921. doi: 10.1371/journal.pone.0086921.

19.

Endoplasmic reticulum aminopeptidase-1 alleles associated with increased risk of ankylosing spondylitis reduce HLA-B27 mediated presentation of multiple antigens.

Seregin SS, Rastall DP, Evnouchidou I, Aylsworth CF, Quiroga D, Kamal RP, Godbehere-Roosa S, Blum CF, York IA, Stratikos E, Amalfitano A.

Autoimmunity. 2013 Dec;46(8):497-508. doi: 10.3109/08916934.2013.819855.

20.

Evolution of highly pathogenic avian influenza (H5N1) virus populations in Vietnam between 2007 and 2010.

Nguyen T, Rivailler P, Davis CT, Hoa do T, Balish A, Dang NH, Jones J, Vui DT, Simpson N, Huong NT, Shu B, Loughlin R, Ferdinand K, Lindstrom SE, York IA, Klimov A, Donis RO.

Virology. 2012 Oct 25;432(2):405-16. doi: 10.1016/j.virol.2012.06.021.

Items per page

Supplemental Content

Support Center